semaglutide prediabetes progression to diabetes Hype or Hope: Evidence-based Review in Diabesity Prediabetes: Symptoms, Causes & Treatment

GLP-1 receptor agonist 7 generates cAMP under the mediation of GLP-1R with an EC50 of 0.2 nM

The FDA has approved the first oral GLP-1 for weight loss

PlexusDx patients receive detailed instructions with every shipment to maximize safety and effectiveness

Learn effectiveness, dosing, & more.

LactoSpore 166mg (Bacillus coagulans) heat-stable probiotic strain for gastrointestinal balance and comfort

As of early 2026, several potent single, dual, and triple incretin receptor agonists are in Phase 2/3 trials for MASH including : Survodutide : A dual glucagon (GCGR)/GLP-1 receptor agonist that has shown significant MASH resolution in Phase 2 trials